Bank Of America Corp Sage Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 671,950 shares of SAGE stock, worth $3.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

671,950

Previous 510,881 31.53%

Holding current value

$3.66 Million

Previous $5.55 Million 12.69%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.02 - $13.08 $1.13 Million - $2.11 Million	161,069 Added 31.53%	671,950 $4.84 Million
Q2 2024 Aug 14, 2024	SELL	$10.58 - $17.9 $145,094 - $245,480	-13,714 Reduced 2.61%	510,881 $5.55 Million
Q1 2024 May 15, 2024	BUY	$18.62 - $26.95 $4.75 Million - $6.87 Million	255,044 Added 94.62%	524,595 $9.83 Million
Q4 2023 Feb 14, 2024	BUY	$17.1 - $22.26 $2.28 Million - $2.97 Million	133,607 Added 98.28%	269,551 $5.84 Million
Q2 2023 Aug 14, 2023	SELL	$40.65 - $59.54 $6.02 Million - $8.82 Million	-148,057 Reduced 52.13%	135,944 $6.39 Million
Q1 2023 May 12, 2023	BUY	$37.27 - $46.57 $1.37 Million - $1.71 Million	36,790 Added 14.88%	284,001 $11.9 Million
Q4 2022 Feb 10, 2023	BUY	$32.2 - $43.61 $1.67 Million - $2.27 Million	51,995 Added 26.63%	247,211 $9.43 Million
Q3 2022 Nov 14, 2022	BUY	$32.28 - $43.27 $1.27 Million - $1.7 Million	39,295 Added 25.2%	195,216 $7.65 Million
Q2 2022 Aug 12, 2022	SELL	$27.52 - $37.99 $2.34 Million - $3.24 Million	-85,167 Reduced 35.33%	155,921 $5.04 Million
Q1 2022 May 16, 2022	BUY	$30.71 - $45.71 $3.04 Million - $4.53 Million	98,996 Added 69.67%	241,088 $7.98 Million
Q4 2021 Feb 08, 2022	BUY	$37.06 - $47.11 $2.25 Million - $2.86 Million	60,790 Added 74.77%	142,092 $6.04 Million
Q3 2021 Nov 15, 2021	SELL	$40.26 - $57.37 $1.05 Million - $1.5 Million	-26,137 Reduced 24.33%	81,302 $3.6 Million
Q2 2021 Sep 13, 2021	BUY	$54.88 - $79.29 $5.9 Million - $8.52 Million	107,439 New	107,439 $6.1 Million

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Sage Therapeutics, Inc. Transaction History